Advertisement
News
Advertisement

Ziopharm gets FDA OK for melanoma therapeutic trial

Fri, 06/10/2011 - 9:36am
Mass High Tech: The Journal of New England Technology

Ziopharm Oncology Inc., a New York company with the bulk of its operations in Charlestown, has been given approval from the U.S. Food and Drug Administration to move its melanoma drug candidate into Phase 1 clinical trials, the company announced in a news release.

With the company’s investigational new drug application accepted, Ziopharm said its DNA-based treatment, ZIN ATI-001, is the second cancer drug product stemming from the company’s partnership with synthetic biology firm Intrexon Corp.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading